IDEAYA Biosciences (IDYA) EPS (Basic) (2018 - 2026)
IDEAYA Biosciences (IDYA) reported EPS (Basic) of -$2.62 for Q1 2026, down 148.95% on a YoY basis from $5.36 in Q1 2025, and down 145.83% sequentially from -$1.07 in Q4 2025.
IDEAYA Biosciences (IDYA) EPS (Basic) (2018 - 2026) Analysis & Trends
IDEAYA Biosciences (IDYA) has 9 years of EPS (Basic) data on file, last reported at -$2.62 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Basic) fell 148.95% year-over-year to -$2.62; the trailing twelve-month figure through Mar 2026 stood at -$4.88 (up 19.65% YoY), and the FY2025 full-year result was -$4.0, up 33.48% from the prior year.
- EPS (Basic) slipped to -$2.62 in Q1 2026, from -$1.07 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.34 in Q3 2025 to a low of -$2.62 in Q1 2026.
- A 5-year average of -$1.01 and a median of -$0.71 in 2024 frame the typical range for EPS (Basic).
- Across the five-year window, EPS (Basic) sank 245.86% in 2024 and jumped 121.86% in 2025, its largest moves.
- Tracing IDYA's EPS (Basic) over 5 years: stood at -$0.61 in 2022, then declined by 11.45% to -$0.68 in 2023, then tumbled by 164.73% to -$1.8 in 2024, then jumped by 40.79% to -$1.07 in 2025, then plunged by 145.83% to -$2.62 in 2026.
- Business Quant data shows IDYA's EPS (Basic) at -$2.62 in Q1 2026, -$1.07 in Q4 2025, and $0.34 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | IDEAYA Biosciences | 3.15 Bn | 2.47 Bn | - | -2.62 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.62 |
| Dec 31, 2025 | -1.07 |
| Sep 30, 2025 | 0.34 |
| Jun 30, 2025 | -1.53 |
| Mar 31, 2025 | -1.05 |
| Dec 31, 2024 | -1.80 |
| Sep 30, 2024 | -1.56 |
| Jun 30, 2024 | -2.07 |
| Mar 31, 2024 | -0.71 |
| Dec 31, 2023 | -0.68 |
| Sep 30, 2023 | -0.56 |
| Jun 30, 2023 | -0.60 |
| Mar 31, 2023 | -0.54 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -0.45 |
| Jun 30, 2022 | -0.98 |
| Mar 31, 2022 | -0.66 |
| Dec 31, 2021 | -0.59 |
| Sep 30, 2021 | -0.31 |
| Jun 30, 2021 | -0.34 |